{"id":431187,"date":"2026-04-29T18:09:00","date_gmt":"2026-04-29T10:09:00","guid":{"rendered":"https:\/\/pingtungtimes.com.tw\/?p=431187"},"modified":"2026-04-29T18:09:00","modified_gmt":"2026-04-29T10:09:00","slug":"%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e6%ad%90%e6%b4%b2%e9%a6%96%e5%80%8b%e5%b8%95%e5%a6%a5%e7%8f%a0%e5%96%ae%e6%8a%97%e7%94%9f%e7%89%a9%e9%a1%9e","status":"publish","type":"post","link":"https:\/\/pingtungtimes.com.tw\/?p=431187","title":{"rendered":"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6"},"content":{"rendered":"
\n

\u4e0a\u6d77<\/span>2026\u5e744\u670829\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae<\/sup>\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7[1]<\/sup>\u3002<\/p>\n

Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0[2],[3]<\/sup>\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe[3],[4]<\/sup>\u3002\u300d<\/p>\n

\u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d<\/p>\n

\u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002<\/p>\n

POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c[5]<\/sup>\u3002<\/p>\n

2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229[6]<\/sup>\u3002<\/p>\n

\u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716
<\/u><\/b>\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015<\/span>\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002<\/p>\n

\u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae<\/sup>\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae<\/sup>\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002<\/p>\n

\u95dc\u65bcOrganon
<\/u><\/b>Organon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002<\/p>\n

Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com<\/a>\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002<\/p>\n

\u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0
<\/u><\/b>\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov<\/a>\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002<\/p>\n

PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002<\/p>\n

\n\n\n\n
\n

1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.
2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2024-01\/jrc_Breast_cancer_2022_Oct_2023.pdf<\/a>
3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf<\/a>
4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf<\/a>
5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview<\/a>
6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

\u00a0<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u4e0a\u6d772026\u5e744\u670829\u65e5 \/\u7f8e…<\/p>\n","protected":false},"author":16,"featured_media":199219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[40567],"tags":[],"class_list":["post-431187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-40567"],"acf":[],"yoast_head":"\n\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831<\/title>\n<meta name=\"description\" content=\"\u4e0a\u6d772026\u5e744\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7\u3002 Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0,\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe,\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d \u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002 POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229\u3002 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002 \u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002 \u95dc\u65bcOrganonOrganon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002 Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002 PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002 1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2024-01\/jrc_Breast_cancer_2022_Oct_2023.pdf3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius' Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/ \u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pingtungtimes.com.tw\/?p=431187\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"og:description\" content=\"\u4e0a\u6d772026\u5e744\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7\u3002 Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0,\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe,\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d \u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002 POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229\u3002 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002 \u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002 \u95dc\u65bcOrganonOrganon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002 Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002 PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002 1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2024-01\/jrc_Breast_cancer_2022_Oct_2023.pdf3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius' Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/ \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pingtungtimes.com.tw\/?p=431187\" \/>\n<meta property=\"og:site_name\" content=\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pingtungnews\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T10:09:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"author\" content=\"\u7f8e\u901a\u793e\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u7f8e\u901a\u793e\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187\"},\"author\":{\"name\":\"\u7f8e\u901a\u793e\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\"},\"headline\":\"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6\",\"datePublished\":\"2026-04-29T10:09:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187\"},\"wordCount\":242,\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"articleSection\":[\"\u7f8e\u901a\u793e\"],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187\",\"name\":\"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"datePublished\":\"2026-04-29T10:09:00+00:00\",\"description\":\"\u4e0a\u6d772026\u5e744\u670829\u65e5 \\\/\u7f8e\u901a\u793e\\\/ -- \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\\\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7\u3002 Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0,\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe,\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d \u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002 POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229\u3002 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002 \u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002 \u95dc\u65bcOrganonOrganon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002 Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002 PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002 1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\\\/\\\/ecis.jrc.ec.europa.eu\\\/sites\\\/default\\\/files\\\/2024-01\\\/jrc_Breast_cancer_2022_Oct_2023.pdf3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\\\/\\\/www.ema.europa.eu\\\/en\\\/documents\\\/leaflet\\\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\\\/\\\/www.iqvia.com\\\/-\\\/media\\\/iqvia\\\/pdfs\\\/library\\\/white-papers\\\/the-impact-of-biosimilar-competition-in-europe-2024.pdf5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\\\/\\\/www.ema.europa.eu\\\/en\\\/human-regulatory-overview\\\/biosimilar-medicines-overview6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius' Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\\\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\\\/\\\/www.organon.com\\\/news\\\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\\\/ \u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#primaryimage\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":\"3000\",\"height\":\"1990\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=431187#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"description\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4\",\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":150,\"height\":150,\"caption\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pingtungnews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\",\"name\":\"\u7f8e\u901a\u793e\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"caption\":\"\u7f8e\u901a\u793e\"},\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u4e0a\u6d772026\u5e744\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7\u3002 Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0,\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe,\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d \u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002 POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229\u3002 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002 \u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002 \u95dc\u65bcOrganonOrganon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002 Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002 PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002 1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2024-01\/jrc_Breast_cancer_2022_Oct_2023.pdf3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius' Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/ \u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pingtungtimes.com.tw\/?p=431187","og_locale":"zh_TW","og_type":"article","og_title":"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","og_description":"\u4e0a\u6d772026\u5e744\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7\u3002 Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0,\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe,\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d \u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002 POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229\u3002 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002 \u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002 \u95dc\u65bcOrganonOrganon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002 Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002 PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002 1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2024-01\/jrc_Breast_cancer_2022_Oct_2023.pdf3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius' Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/ \u00a0","og_url":"https:\/\/pingtungtimes.com.tw\/?p=431187","og_site_name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","article_publisher":"https:\/\/www.facebook.com\/pingtungnews","article_published_time":"2026-04-29T10:09:00+00:00","og_image":[{"url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","type":"","width":"","height":""}],"author":"\u7f8e\u901a\u793e","twitter_card":"summary_large_image","twitter_image":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","twitter_misc":{"\u4f5c\u8005:":"\u7f8e\u901a\u793e","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#article","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=431187"},"author":{"name":"\u7f8e\u901a\u793e","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3"},"headline":"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6","datePublished":"2026-04-29T10:09:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=431187"},"wordCount":242,"publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","articleSection":["\u7f8e\u901a\u793e"],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/pingtungtimes.com.tw\/?p=431187","url":"https:\/\/pingtungtimes.com.tw\/?p=431187","name":"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#primaryimage"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","datePublished":"2026-04-29T10:09:00+00:00","description":"\u4e0a\u6d772026\u5e744\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207 Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08European Commission, EC\uff09\u5df2\u6279\u51c6POHERDY\u00ae\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09420 mg\/14 mL\u975c\u8108\u6ce8\u5c04\u6db2\u7684\u4e0a\u5e02\u8a31\u53ef\u3002\u8a72\u7522\u54c1\u662f\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684PERJETA\uff08\u5e15\u59a5\u73e0\u55ae\u6297\uff09\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u7372\u6279\u9069\u7528\u65bc\u53c3\u6bd4\u5236\u5291\u7684\u5168\u90e8\u9069\u61c9\u75c7\u3002 Organon\u526f\u7e3d\u88c1\u3001\u5168\u7403\u751f\u7269\u985e\u4f3c\u85e5\u5546\u696d\u8ca0\u8cac\u4ebaJoe Azzinaro\u8868\u793a\uff1a\u300c\u4f5c\u70ba\u6b50\u6d32\u9996\u500b\u4e14\u76ee\u524d\u552f\u4e00\u7372\u6279\u7684\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\uff0cPOHERDY\u7684\u7372\u6279\u6a19\u8a8c\u8457\u5728\u63d0\u5347\u7279\u5b9aHER2\u967d\u6027\u4e73\u817a\u764c\u60a3\u8005\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002\u4e73\u817a\u764c\u662f\u5973\u6027\u4e2d\u6700\u5e38\u898b\u7684\u60e1\u6027\u816b\u7624\u4e4b\u4e00\uff0c\u4e5f\u662f\u6b50\u76df\u5973\u6027\u764c\u75c7\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0,\u3002Organon\u4e0d\u65b7\u8c50\u5bcc\u7684\u751f\u7269\u985e\u4f3c\u85e5\u5168\u7403\u7522\u54c1\u7d44\u5408\uff0c\u9032\u4e00\u6b65\u5f70\u986f\u4e86\u6211\u5011\u5728\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u540c\u6642\uff0c\u6301\u7e8c\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u3001\u63d0\u5347\u512a\u8cea\u85e5\u7269\u53ef\u53ca\u6027\u7684\u5805\u5b9a\u627f\u8afe,\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9ad8\u7d1a\u526f\u7e3d\u88c1\u3001\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u66f9\u5e73\u8868\u793a\uff1a\u300c\u7e7cPOHERDY\u5728\u7f8e\u570b\u7372\u6279\u6210\u70ba\u8a72\u5e02\u5834\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u4e4b\u5f8c\uff0c\u6b64\u6b21\u5728\u6b50\u76df\u7372\u6279\u9032\u4e00\u6b65\u62d3\u5c55\u4e86\u6211\u5011\u5728\u5168\u7403\u5e02\u5834\u7684\u751f\u7269\u985e\u4f3c\u85e5\u7522\u54c1\u4f48\u5c40\uff0c\u4e5f\u9ad4\u73fe\u4e86\u6211\u5011\u8207Organon\u7a69\u56fa\u800c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\u95dc\u4fc2\u3002\u5728\u5805\u6301\u79d1\u5b78\u56b4\u8b39\u8207\u7522\u54c1\u8cea\u91cf\u7684\u57fa\u790e\u4e0a\uff0c\u6211\u5011\u5c07\u6301\u7e8c\u81f4\u529b\u65bc\u70ba\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7642\u9078\u64c7\u3001\u63d0\u5347\u53ef\u53ca\u6027\uff0c\u9020\u798f\u60a3\u8005\u4e26\u52a9\u529b\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55\u3002\u300d \u5728\u6b50\u6d32\uff0cPOHERDY\u9069\u7528\u65bc\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u591a\u897f\u4ed6\u8cfd\uff0c\u7528\u65bc\u6cbb\u7642\u65e2\u5f80\u672a\u63a5\u53d7\u6297HER2\u6cbb\u7642\u6216\u91dd\u5c0d\u8f49\u79fb\u6027\u75be\u75c5\u5316\u7642\u7684HER2\u967d\u6027\u8f49\u79fb\u6027\u6216\u5c40\u90e8\u5fa9\u767c\u4e14\u4e0d\u53ef\u5207\u9664\u7684\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002\u6b64\u5916\uff0cPOHERDY\u9084\u53ef\u806f\u5408\u66f2\u59a5\u73e0\u55ae\u6297\u53ca\u5316\u7642\u7528\u65bc\uff1a\uff08i\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u5c40\u90e8\u665a\u671f\u3001\u708e\u6027\u6216\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u65b0\u8f14\u52a9\u6cbb\u7642\uff1b\uff08ii\uff09\u9ad8\u5fa9\u767c\u98a8\u96aa\u7684HER2\u967d\u6027\u65e9\u671f\u4e73\u817a\u764c\u6210\u4eba\u60a3\u8005\u7684\u8f14\u52a9\u6cbb\u7642\u3002 POHERDY\u7684\u7372\u6279\u57fa\u65bc\u5c0d\u4e00\u6574\u5957\u5b8c\u6574\u6578\u64da\u8cc7\u6599\u7684\u5be9\u8a55\uff0c\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u6578\u64da\u4ee5\u53ca\u5c0d\u6bd4\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u9019\u4e9b\u7814\u7a76\u5f9e\u6574\u9ad4\u8b49\u64da\uff08totality of evidence\uff09\u51fa\u767c\uff0c\u6db5\u84cb\u5206\u6790\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\u3001\u7642\u6548\u3001\u5b89\u5168\u6027\u53ca\u514d\u75ab\u539f\u6027\uff08\u5373\u751f\u7269\u5236\u5291\u5f15\u767c\u514d\u75ab\u53cd\u61c9\u7684\u5167\u5728\u80fd\u529b\uff09\u7b49\u591a\u500b\u65b9\u9762\uff0c\u5145\u5206\u8b49\u660ePOHERDY\u5728\u5404\u9805\u95dc\u9375\u6307\u6a19\u4e0a\u5747\u8207\u53c3\u6bd4\u5236\u5291\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u9054\u6210\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5305\u62ecPOHERDY\u5728\u5167\u7684\u591a\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u5728\u4e2d\u570b\u4ee5\u5916\u5168\u7403\u7bc4\u570d\u5167\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u5229\u3002 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u5275\u65b0\u751f\u7269\u88fd\u85e5\u4f01\u696d\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u9ad8\u54c1\u8cea\u3001\u53ef\u8ca0\u64d4\u7684\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u516c\u53f8\u5df2\u69cb\u5efa\u6db5\u84cb\u5168\u7403\u7814\u767c\u3001\u81e8\u5e8a\u3001\u8a3b\u518a\u3001\u751f\u7522\u53ca\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u5e73\u53f0\uff0c\u64c1\u6709\u5168\u7403\u54e1\u5de5\u8fd14,000\u4eba\uff0c\u4e26\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u65e5\u672c\u7b49\u591a\u5730\u8a2d\u6709\u904b\u71df\u53ca\u5206\u652f\u6a5f\u69cb\u3002\u4f9d\u6258\u751f\u7269\u985e\u4f3c\u85e5\u5f62\u6210\u7684\u7a69\u5065\u73fe\u91d1\u6d41\u53cd\u54fa\u5275\u65b0\u7814\u767c\uff0c\u5fa9\u5b8f\u6f22\u9716\u6b63\u7a69\u6b65\u9081\u5165\u300c\u5168\u7403\u53162.0\u300d\u968e\u6bb5\uff0c\u6301\u7e8c\u6253\u9020\u53ef\u8907\u88fd\u3001\u53ef\u6301\u7e8c\u7684\u5168\u7403\u589e\u9577\u6a21\u5f0f\u3002\u622a\u81f32026\u5e74\u521d\uff0c\u516c\u53f8\u5171\u670910\u6b3e\u7522\u54c1\u5728\u5168\u740360\u9918\u500b\u570b\u5bb6\u548c\u5730\u5340\u7372\u6279\u4e0a\u5e02\uff0c\u5176\u4e2d7\u6b3e\u5df2\u5728\u4e2d\u570b\u7372\u6279\u3002\u5728\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\uff0c\u5fa9\u5b8f\u6f22\u9716\u4ea6\u53d6\u5f97\u591a\u9805\u91cc\u7a0b\u7891\u5f0f\u7a81\u7834\uff0c\u5df2\u67094\u6b3e\u7522\u54c1\u7372\u5f97\u7f8e\u570bFDA\u6279\u51c6\u30015\u6b3e\u7522\u54c1\u7372\u5f97\u6b50\u76dfEC\u6279\u51c6\uff0c\u5145\u5206\u9ad4\u73fe\u4e86\u516c\u53f8\u5728\u7814\u767c\u9ad4\u7cfb\u3001\u8cea\u91cf\u7ba1\u7406\u53ca\u751f\u7522\u80fd\u529b\u65b9\u9762\u5df2\u5168\u9762\u5c0d\u6a19\u570b\u969b\u6700\u9ad8\u6a19\u6e96\u3002 \u5728\u5275\u65b0\u9a45\u52d5\u65b9\u9762\uff0c\u5fa9\u5b8f\u6f22\u9716\u4f9d\u6258\u4e0a\u6d77\u3001\u7f8e\u570b\u7b49\u591a\u5730\u5354\u540c\u4f48\u5c40\u7684\u7814\u767c\u9ad4\u7cfb\uff0c\u69cb\u5efa\u4e86\u591a\u5143\u5316\u3001\u5e73\u53f0\u5316\u7684\u5275\u65b0\u6280\u8853\u77e9\u9663\uff0c\u8986\u84cb\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u514d\u75ab\u7d30\u80de\u929c\u63a5\u5668\uff08\u5305\u62ec\u591a\u7279\u7570\u6027TCE\uff09\u3001\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u4ee5\u53caAI\u9a45\u52d5\u7684\u65e9\u671f\u7814\u767c\u5e73\u53f0\u7b49\u524d\u6cbf\u65b9\u5411\u3002\u76ee\u524d\uff0c\u516c\u53f8\u64c1\u670950\u9918\u9805\u8655\u65bc\u65e9\u671f\u968e\u6bb5\u7684\u5275\u65b0\u8cc7\u7522\uff0c\u5176\u4e2d\u7d0470%\u5177\u5099\u540c\u985e\u6700\u4f73\uff08Best-in-Class\uff09\u6f5b\u529b\uff0c\u4e26\u5728\u5168\u7403\u540c\u6b65\u63a8\u903230\u9918\u9805\u81e8\u5e8a\u7814\u7a76\u3002\u6838\u5fc3\u7522\u54c1H\u85e5 \u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u4f5c\u70ba\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\uff0c\u6b63\u52a0\u901f\u5168\u7403\u4f48\u5c40\uff0c\u5df2\u5728\u5168\u740340\u9918\u500b\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff1b\u540c\u6642\uff0c\u591a\u6b3e\u6f5b\u529b\u5275\u65b0\u8cc7\u7522\uff0c\u5305\u62ecPD-L1 ADC HLX43\u53ca\u65b0\u8868\u4f4dHER2\u55ae\u6297HLX22\u6b63\u5168\u9762\u63a8\u9032\u5168\u7403\u95dc\u9375\u6027\u81e8\u5e8a\u7814\u7a76\u3002\u4f9d\u6258\u901a\u904e\u4e2d\u3001\u6b50\u3001\u7f8e\u4e09\u5730GMP\u8a8d\u8b49\u7684\u751f\u7522\u9ad4\u7cfb\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u7e3d\u7522\u80fd\u905484,000\u5347\u7684\u751f\u7269\u85e5\u751f\u7522\u5e73\u53f0\uff0c\u5f62\u6210\u8986\u84cb\u5168\u7403\u516d\u5927\u6d32\u7684\u7a69\u5b9a\u4f9b\u61c9\u7db2\u7d61\u3002\u672a\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5c07\u59cb\u7d42\u5805\u6301\u4ee5\u60a3\u8005\u70ba\u4e2d\u5fc3\uff0c\u805a\u7126\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\uff0c\u6301\u7e8c\u63a8\u52d5\u5275\u65b0\u6210\u679c\u5411\u81e8\u5e8a\u50f9\u503c\u8207\u60a3\u8005\u53ef\u53ca\u8f49\u5316\uff0c\u5728\u5168\u7403\u751f\u7269\u91ab\u85e5\u5275\u65b0\u751f\u614b\u4e2d\u5275\u9020\u9577\u671f\u800c\u7a69\u5065\u7684\u50f9\u503c\u3002 \u95dc\u65bcOrganonOrganon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4ee5\u63d0\u4f9b\u5275\u65b0\u6027\u7684\u85e5\u54c1\u548c\u89e3\u6c7a\u65b9\u6848\uff0c\u5be6\u73fe\u66f4\u5065\u5eb7\u7684\u6bcf\u4e00\u5929\u70ba\u4f7f\u547d\u3002Organon\u5728\u5168\u7403\u63d0\u4f9b\u8d85\u904e70\u7a2e\u85e5\u7269\u548c\u91ab\u7642\u89e3\u6c7a\u65b9\u6848\uff0c\u4e26\u6301\u7e8c\u63a8\u52d5\u9019\u4e9b\u4e9f\u9700\u7642\u6cd5\u5728\u8d85140\u500b\u5e02\u5834\u7684\u5ee3\u6cdb\u53ef\u53ca\uff0c\u91cd\u9ede\u696d\u52d9\u5305\u62ec\u5973\u6027\u5065\u5eb7\u8207\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\u5728\u5167\u7684\u7d93\u5178\u7522\u54c1\uff0c\u5c08\u6ce8\u65bc\u70ba\u5973\u6027\u7279\u6709\u75be\u75c5\u3001\u5c0d\u5973\u6027\u5f71\u97ff\u91cd\u5927\u6216\u4e0d\u540c\u7684\u75be\u75c5\u5c0b\u6c42\u89e3\u6c7a\u65b9\u6848\u3002 Organon\u7e3d\u90e8\u8a2d\u5728\u7f8e\u570b\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\uff0c\u81f4\u529b\u65bc\u63d0\u5347\u91ab\u85e5\u5065\u5eb7\u9818\u57df\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u548c\u5275\u65b0\u767c\u5c55\u3002\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u4ee5\u77ad\u89e3\u66f4\u591a\u6709\u95dcOrganon\u7684\u4fe1\u606f\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805\u00a0\u672c\u65b0\u805e\u7a3f\u5305\u542b\u300a1995\u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\uff08US Private Securities Litigation Reform Act of 1995\uff09\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u754c\u5b9a\u7684\u300c\u524d\u77bb\u6027\u8072\u660e\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcPOHERDY\u7684\u6cbb\u7642\u76ee\u6a19\uff0c\u4ee5\u53caOrganon\u901a\u904e\u63d0\u4f9b\u512a\u8cea\u85e5\u7269\u3001\u5728\u4fc3\u9032\u5973\u6027\u5065\u5eb7\u7684\u540c\u6642\u6301\u7e8c\u652f\u6301\u91ab\u7642\u9ad4\u7cfb\u53ef\u6301\u7e8c\u767c\u5c55\u7684\u76f8\u95dc\u627f\u8afe\u3002\u524d\u77bb\u6027\u8072\u660e\u901a\u5e38\u53ef\u901a\u904e\u300c\u5c07\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u81f4\u529b\u65bc\u652f\u6301\u300d\u3001\u300c\u53ef\u80fd\u300d\u7b49\u8a5e\u8a9e\u53ca\u985e\u4f3c\u8868\u9054\u52a0\u4ee5\u8b58\u5225\u3002\u4e0a\u8ff0\u8072\u660e\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u4fe1\u5ff5\u548c\u9810\u671f\uff0c\u53d7\u5230\u591a\u9805\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\u3002\u82e5\u76f8\u95dc\u5047\u8a2d\u88ab\u8b49\u660e\u4e0d\u6e96\u78ba\uff0c\u6216\u76f8\u95dc\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u767c\u751f\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u56e0\u7d20\uff0c\u53ef\u53c3\u898bOrganon\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec\u5176\u6700\u65b0\u7684Form 10-K\u5e74\u5ea6\u5831\u544a\u53ca\u5176\u4ed6\u76f8\u95dc\u62ab\u9732\u6587\u4ef6\uff0c\u8a73\u898bSEC\u5b98\u65b9\u7db2\u7ad9\uff08www.sec.gov\uff09\u3002\u9664\u975e\u6cd5\u5f8b\u53e6\u6709\u8981\u6c42\uff0cOrganon\u4e0d\u627f\u64d4\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u5c0d\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u9032\u884c\u516c\u958b\u66f4\u65b0\u7684\u7fa9\u52d9\u3002 PERJETA \u662f F. Hoffmann-La Roche AG \u5728\u6b50\u76df\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6240\u6709\u8005\u6c92\u6709\u4efb\u4f55\u95dc\u806f\u3002 1. \u00a0 \u00a0PERJETA. Product Information. Genentech, Inc.; 2025.2. \u00a0 \u00a0Breast cancer in the EU. European Commission, Joint Research Centre. October 2023. Accessed April 14, 2026. https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2024-01\/jrc_Breast_cancer_2022_Oct_2023.pdf3. \u00a0 \u00a0European Medicines Agency and the European Commission. Biosimilars in the EU: information guide for healthcare professionals. European Medicines Agency (EMA). Last Updated October 29, 2019. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf4. \u00a0 \u00a0Troein P, Newton M, Stoddart K, Travaglio M, Arias A. The impact of biosimilar competition in Europe. IQVIA; January 2025. Accessed April 14, 2026. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf5. \u00a0 \u00a0Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed April 14, 2026. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview6. \u00a0 \u00a0Organon Enters into Global License Agreement to Commercialize Henlius' Investigational Perjeta \u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed April 14, 2026. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/ \u00a0","breadcrumb":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pingtungtimes.com.tw\/?p=431187"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#primaryimage","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":"3000","height":"1990"},{"@type":"BreadcrumbList","@id":"https:\/\/pingtungtimes.com.tw\/?p=431187#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/pingtungtimes.com.tw\/"},{"@type":"ListItem","position":2,"name":"\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u6b50\u6d32\u9996\u500b\u5e15\u59a5\u73e0\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5POHERDY\u00ae\u7372\u6b50\u76df\u59d4\u54e1\u6703\u6279\u51c6"}]},{"@type":"WebSite","@id":"https:\/\/pingtungtimes.com.tw\/#website","url":"https:\/\/pingtungtimes.com.tw\/","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4","publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pingtungtimes.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/pingtungtimes.com.tw\/#organization","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","url":"https:\/\/pingtungtimes.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":150,"height":150,"caption":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pingtungnews"]},{"@type":"Person","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3","name":"\u7f8e\u901a\u793e","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","caption":"\u7f8e\u901a\u793e"},"url":"https:\/\/pingtungtimes.com.tw\/?author=16"}]}},"_links":{"self":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/431187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=431187"}],"version-history":[{"count":0,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/431187\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/media\/199219"}],"wp:attachment":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=431187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=431187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=431187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}